CN1037539A - The manufacture method of new antitumor antibiotic C-1027 - Google Patents

The manufacture method of new antitumor antibiotic C-1027 Download PDF

Info

Publication number
CN1037539A
CN1037539A CN 88102759 CN88102759A CN1037539A CN 1037539 A CN1037539 A CN 1037539A CN 88102759 CN88102759 CN 88102759 CN 88102759 A CN88102759 A CN 88102759A CN 1037539 A CN1037539 A CN 1037539A
Authority
CN
China
Prior art keywords
chromatography
manufacture method
bacterial strain
substratum
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 88102759
Other languages
Chinese (zh)
Inventor
胡继兰
甄永苏
大古敏夫
张瑞
解美玉
松本宏
南庆典
丸中照义
齐藤等
山田雄次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Medicinal Biotechnology of CAMS
Original Assignee
Institute of Medicinal Biotechnology of CAMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Medicinal Biotechnology of CAMS filed Critical Institute of Medicinal Biotechnology of CAMS
Priority to CN 88102759 priority Critical patent/CN1037539A/en
Publication of CN1037539A publication Critical patent/CN1037539A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A kind of new large-molecular peptides antitumorigenic substance C-1027, be to become strain with the bacterial strain that can produce this material or its, under the suitable culture condition, cultivate (pH of substratum with neutrality for well, culture temperature is 20-37 ℃ of scopes, general 2-5 days of incubation time), its product C-1027 can adopt the method for general separation and Extraction tunning to carry out, as saltout, the hydrophobicity chromatography, ion exchange chromatography, adsorption chromatography, gel permeation chromatography etc., can be separately or the arbitrary combination mode carry out, centrifugal then, separate, filter, refining repeatedly, lyophilize, make pure product, this material has tangible anti-tumor activity, and curative effect is better than the Zorubicin and the ametycin of clinical use.

Description

The manufacture method of new antitumor antibiotic C-1027
The present invention relates to a kind of manufacture method of new large-molecular peptides antitumor antibiotics.
The C-1027 microbiotic is in the process of screening antitumor antibiotics, from the actinomycetic fermented liquid of nearly 2000 strains, detected with spermatogonium, not only have stronger anti-tumor activity, and also have the effect of resisting gram-positive bacterium and anti-gram negative bacterium, but there is not antimycotic effect.The C-1027 microbiotic that the present invention relates to after testing and consult existing technical information, all found no report, so can be defined as a new compound.
The objective of the invention is new antibiotic, with antitumor antibiotics kind deficiency or the not good enough problem of curative effect that solves present clinical use for providing one to have better antitumor action.
Main points of the present invention are to cultivate under proper condition by having the bacterial strain (call C-1027 in the following text and produce bacterium) that produces the C-1027 ability, and separation from nutrient solution, extraction obtain this material.
The generation bacterium that is used to make C-1027 is streptomyces bacterial strain C-1027, and available Streptomyces globisporus var.qianjiangensis n.var.C-1027 represents.This bacterial strain obtains from the separation of Qianjiang county, Chinese Hubei Province soil, (in the former Japanese patent specification mistake be written as " Chinese yunnan soil "), and be preserved in China Committee for Culture Collection of Microorganisms common micro-organisms center for No. 0135 with CGMCC NO.It is as follows that little rz thing of this bacterial strain is learned character:
Morphological specificity:
The fibrillae of spores of C-1027 bacterial strain is until ripple song (Fig. 1), 10 to 30 on every chain of sophisticated spore chain or more spore, spore cylindricality, smooth surface (Fig. 2).
Cultural characteristic:
The C-1027 bacterial strain is at various synthetic or organically form white to yellowish aerial hyphae on the substratum, often has little brown or light cinnamon color.
Substrate mycelium is general colourless or butterfat is yellowish, and pale yellow ash or ecru do not have specific color.
On the substratum of being tested, do not produce soluble pigment.The cultural characteristic of C-1027 sees table 1 for details.
The physiological characteristic of C-1027 sees Table 2.
The former utilization spectrum of the carbon of C-1027 sees Table 3.
The full cellular water hydrolysis products of C-1027 bacterial strain contains LL-diaminopimelic acid and glucose, ribose.
The cultural characteristic of table 1 C-1027 bacterial strain
Substratum growth aerial mycelium substrate mycelium soluble pigment
The luxuriant nude of ISP NO2 is to yellow ash or the yellow nothing of the yellow shallow moccasin of light olive moccasin or pale yellow
ISP NO3 appropriateness is pale yellow whitely not to be had to the yellow colourless or butterfat of light olive moccasin
ISP NO3 appropriateness is pale yellow whitely not to be had to the yellow colourless or butterfat of light olive moccasin
The yellow colourless or butterfat of the luxuriant pale yellow ash of ISP NO5 or light olive moccasin does not have
ISP NO6 is thin white to light yellow pale yellow nothing
The yellow colourless or ecru of the luxuriant pale yellow ash of ISP NO7 or light olive moccasin does not have
Czapek's agar (sucrose) is thin pale yellow white to the yellow colourless nothing of light olive moccasin
Czapek's agar (glucose) is luxuriant pale yellowly white not to be had to the yellow colourless or butterfat of light olive moccasin
The yellow colourless or pale yellow ash of luxuriant pale yellow ash of No. 1 agar of Gao Shi or light olive moccasin does not have
The yellow colourless nothing of glucose asparagine agar pale yellow ash of appropriateness or light olive moccasin
Pale yellow or the nothing of the white extremely pale yellow ash of Bennetts agar appropriateness
The luxuriant light olive moccasin of potato agar is yellow colourless to the yellow nothing of olive moccasin
The physiological property of table 2 C-1027 bacterial strain
The observation item feature
Melanochrome produces
ISP NO1 substratum feminine gender
ISP NO6 substratum feminine gender
ISP NO7 substratum feminine gender
H 2The generation positive of S
The gelatine liquefication positive
Cow's milk: solidify the positive
Peptonize the positive
The nitrate reductase positive
The temperature (ISP NO2 substratum) of growth
28-32 ℃ is luxuriant, and growth is rapid,
37 ℃ of appropriateness, slow
Do not grow for 45 ℃
The utilization of carbon source spectrum of table 3 C-1027 bacterial strain
Carbon source for growth
L-arabinose ++ ++
The D-wood sugar +++
D-glucose +++
D-fructose ++ ++
Sucrose-
Inositol-
The L-rhamnosyl ++ ++
D-N.F,USP MANNITOL ++ ++
The D-semi-lactosi ++ ++
Lactose-
Mierocrystalline cellulose-
Melampyrin-
Saligenin+
Raffinose-
Result of study based on features such as form, cultivation, Physiology and biochemistry, cell wall analyses shows that the C-1027 bacterial strain should belong to the ball spore monoid of streptomyces.All very similar to styreptomyces globispotus strain Streptomyces globispous with west tang style streptomycete Streptomyces setonii.Show through comparative result under same culture condition, C-1027 bacterial strain and styreptomyces globispotus strain are more approaching but still have 3 differences, are decided to be the Streptomyces setonii C-1027 west streptomycete C-1027 of Tang so the C-1027 bacterial strain named to styreptomyces globispotus strain Qianjiang mutation Stretomyces globisporus var qianjiangensis n.var.(Japanese patent specification)
C-1027 material of the present invention can be cultivated, make under suitable condition with above-mentioned C-1027 bacterial strain, should vibrate under aerobic environment usually, ventilation, stir culture.
C-1027 produces the employed substratum of bacterium, and for well, various synthetic, semi-synthetic or natural mediums all can use with the substratum that contains the available nutritive substance of this bacterium.The carbon source that substratum is formed has that glucose, fructose, glycerine, lake essence, starch, sugar are close, corn steep liquor, organic acid etc., can use or be used in combination by single degree.Nitrogenous source has organic nitrogen sources such as peptone, meat extract, yeast extract paste, soyflour, casein food grade, amino acid, urea and SODIUMNITRATE, ammonium sulfate etc. inorganic nitrogen-sourced, can be used singly or in combination.Also can in substratum, look it and need suitably to add sodium salt, sylvite, magnesium salts, phosphoric acid salt and other heavy metallic salt class.
Produce foam in the culturing process, can add foam killers such as senior alcohols such as soybean oil, Semen Lini oil and stearyl alcohol, tetradecyl alcohol, heptadecanol or various silicides.
For well, culture temperature is 20-37 ℃ of scope, optimum temps 27-30 ℃ with neutrality for the PH of substratum.Incubation time is generally between 2-5 days.Cultivate by above-mentioned culture condition, can constantly put aside out the C-1027 material.Above-mentioned various culture condition, the kind of visual microorganism used therefor, characteristic and various external conditions appropriate change also can be adjusted and be selected optimum condition in above-mentioned scope.
By the C-1027 material that above-mentioned cultivation produces, its separation and Extraction can adopt the method for general extraction tunning to carry out, as saltout, hydrophobicity chromatography, ion exchange chromatography, adsorption chromatography, gel permeation chromatography etc., can be separately or the mode of arbitrary combination carry out.
Separating and extracting method is: will be present in the C-1027 material in the nutrient solution, at first filtration, centrifugal separates filtrate and mycelium.Get filtrate and add ammonium sulfate precipitation, will contain the throw out centrifugation of C-1027 then or add and help the filter powder to filter.In order to be beneficial to precipitation, can add precipitation agents such as ferric sulfate, iron trichloride, Tai-Ace S 150.As making solution PH that bigger variation take place because of adding precipitation agent, can add neutralizing agents such as yellow soda ash, salt of wormwood, SODIUM PHOSPHATE, MONOBASIC earlier, PH is remained between the 5-8, above-mentioned salting-out process can carry out repeatedly.
Above-described throw out, water-soluble or suitable damping fluid such as Tris-hydrochloride buffer, phosphoric acid buffer etc. are used the cellophane film again, and are after the desalinations such as the outer filtration membrane of limit, further refining.Strong basic ion exchange resins such as refining available Dowex.1 Amberlite IRA-400, weak-base ion-exchange resins such as Amberlite IR-45, DEAE-cellulose, help sorbent materials such as filter powder, Hydroxy phosphatic rock, with the C-1027 aqueous solution by adsorbing, and then wash-out, can remove impurity.Elutriant is through ion exchange resin Sephadex and Cellulose absorption, with wash-outs such as the Nacl aqueous solution, Tris-hydrochloride buffer, phosphoric acid buffers.After the filtering and concentrating, again through Sephadex G-50, the G-75 isogel filters refining this elutriant, preferably obtains pure product outside limitting, and contained low molecule salt can pass through Sephadex G-25 chromatography, and means such as the outer filtration of limit, dialysis are removed.Carry out repeatedly with above-mentioned various chromatography, will more help removing impurity.
After adopting above-mentioned various method for refining and making up the lyophilize of resulting C-1027 refined liquid, can obtain the C-1027 white powder.
The C-1027 of gained of the present invention is an one matter, show that by the SDS-polyacrylamide gel electrophoresis single band, Sephadex G-50 column chromatography show that symmetrical simple spike, TSK-gel G-2000SW high performance liquid chromatography are that simple spike, LKB iso-electric point electrophoresis are single band, all can be confirmed.
The physico-chemical property of C-1027 material is as follows:
Proterties: white powder
Solvability: soluble in water, be insoluble to organic solvents such as methyl alcohol, acetone, vinyl acetic monomer.
Ultra-violet absorption spectrum: in the result who measures among water, 0.01N Hcl, the 0.01N NaOH respectively shown in the curve among Fig. 31,2,3, from figure, can be observed, 270-275,350-360nm in neutrality, acidic aqueous solution, there is obtained the maximum absorption at 270-275,340-345nm place in basic solution.
Infrared absorption spectrum: with KBr sheet measurement result, as shown in Figure 4, mainly be absorbed in 3300,1640,1530cm -1The place.
Fusing point: no sharp melting point R decomposition point, very long browning, blackening in foaming, 260 ℃ of complete charings.
Color reaction: triketohydrindene hydrate, biuret, Folin-Lowry reacting positive, anthrone, aniline one phthalic acid reaction negative.
Iso-electric point: PH 3.5-3.7
Acid-basicity: acidity
Ultimate analysis: C45.22%, H6.65%, N14.03%
Molecular weight: utilize TSK gelG-2000SW high performance gel filtration chromatography and sds polyacrylamide gel electrophoresis method to calculate molecular weight and be about 15,000.
Amino acid is formed: 6NHCl, 110 ℃ of hydrolysis 20 hours are measured and amino acid containedly be the results are shown in Table 4.Detecting it amino acid containedly has: aspartic acid, Threonine, Serine, L-glutamic acid, proline(Pro), glycine, tyrosine, leucine, L-Ala, Gelucystine, Xie Ansuan, Isoleucine, phenylalanine, Histidine, Methionin, arginine and halfcystine is to form with S-sulfocysteine, tryptophane is detected after the NaOH hydrolysis.
-terminal amino acid: detecting-terminal amino acid according to the DNP method is L-Ala.
Table 4 C-1027 amino acid group
Amino acid weight % amino acid weight % amino acid weight %
Aspartic acid 6.16 Threonines 6.27 Serines 8.97
L-glutamic acid 4.74 proline-4 .96 glycine 6.41
L-Ala 9.36 Gelucystines 1.90 Xie Ansuans 6.85
Methionine(Met) 0 Isoleucine 0.76 leucine 3.76
Tryptophane 0 tyrosine 2.76 phenylalanines 4.78
Histidine 1.19 Methionins 1.10 arginine 1.14
Biological activity of the present invention shows: the C-1027 material has stronger restraining effect to the gram positive bacterium growth, and its antimicrobial spectrum is as shown in table 5.The C-1027 material also has tangible anti-tumor activity, and the in vitro tests effect is very strong.Generate the assay method inspection with the clone, to human hepatocellular carcinoma BEL-7402 cell's half casualty-producing concentrations (IC 50) be 0.000013 μ m, its specific activity Zorubicin and ametycin are strong.(the IC of Zorubicin and ametycin 50Be respectively 0.00084 μ M and 0.0059 μ M).The C-1027 material is to mouse L 1210And P 388Leukemia has obvious restraining effect.Inoculation leukemia cell in the DBA mouse peritoneal, 24 hours venter posterior intracavitary administration C-1027 once, 60 days observationss.This material comprises ehrlich carcinoma, H to the mouse ascites cancer 22Ascites liver cancer all has the obvious suppression effect.Kunming mouse intraperitoneal inoculation cancer cells, 24 hours venter posterior intracavitary administration C-1027 materials, 60 days observationss.Above curative effect all sees Table 6.
The C-1027 material comprises S to the mouse transplanted solid tumor 180Interior knurl, U 14Cervical cancer and Harding-passey melanoma all have the obvious suppression effect.The subcutaneous vaccination tumour, shot C-1027 material in 24 hours posterior veins sees Table 7 to the melanomatous inhibiting rate of Harding-passy.
The anti-microbial activity of table 5 C-1027 material
Test organisms minimum inhibitory concentration mcg/ml
Streptococcus aureus 209P 0.78
Bacillus subtilus 6,633 0.78
Sarcine 0.78
Bacillus proteus 0 * 19>100
Intestinal bacteria B 3.13
Intestinal bacteria 0,111 50
Klebsiella pneumoniae 25
Dysentery bacterium 302>100
Green pus liver bacterium 11>100
Mycobacterium 607 (3.13)
Mycobacterium phlei 1.56
Candida albicans>100
Penicillin 5404>100
Spermatogonium 0.0039
Annotate: it is clear that () expression suppresses the circle blur margin.
Table 6 C-1027 material anti-tumor activity
Tumour title dosage (mg/kg) administration number of times lifetime (my god) increase in life span (%)
Leukemia 0.025 1>60>275
L 12100.012 1 >60 >275
0.006 1 >60 >275
Contrast 16
Leukemia 0.025 1>60>275
P 388, 0.012 1 >60 >275
0.006 1 22 37.5
Contrast 16
Ascites liver cancer 0.025 1 38.5 156
H 220.012 1 48 220
0.006 1 22 47
Contrast 15
Table 7 C-1027 material anti-tumor activity
The tumour title Dosage The animal dead number Knurl heavy (gram) Inhibiting rate (%) The P value
Harding-Passey melanoma 0.2 0.1 0.05 contrasts 1 0 0 0 0.20 0.56 0.75 2.98 93 81 75 <0.01 <0.01 <0.01
In addition, the C-1027 material is to KB cells in vitro fragmentation effect ED 50(50% effective dose) is fine, and median effective dose has only 0.001-0.0001 μ g/ml.
Embodiment is as follows for C-1027 material manufacture method:
Glycerine 2%, dextrin 2%, Soytone1%, yeast extract paste 0.3%(NH 4) 2SO 40.2%, CaCO 30.2%, substratum PH6.6 adds the 100ml medium sterilization in the 500ml triangular flask, the C-1027 bacterium is gone in inoculation, and 27 ℃, 48 hours (180 rev/mins, amplitude 10cm) are cultivated in the rotation concussion.And then with glycerine 2%, dextrin 2.0%, fish meal 1%, (NH 4) 2SO 40.2%, CaCO 20.2%, adorns 100ml in the PH6.8 substratum 500ml triangular flask, sterilization.Above-mentioned seed plants with 5% amount, cultivates 96 hours for 27 ℃.
After having cultivated, centrifugal, the filtration of the nutrient solution 10l that gets PH8.0 obtains 7l filtrate, transfers PH4 with HCl, adds 3.5Kg(NH 4) 2SO 4, 5 ℃ were stirred 3 hours, and the C-1027 precipitation and centrifugal separation of separating out (5 ℃, 3000 change, 30 minutes) obtains.This precipitation is dissolved in 400ml deionized water, dialysis, lyophilize and gets meal 5.3g.
Above-mentioned meal 2g is dissolved in the 400ml deionized water, centrifugal (5 ℃, 3000 change, 30 minutes), removes insolubles.Activator adsorbs through the DEAE-Cellulose post, after the washing of 400ml deionization, and 0.1MNacl wash-out, active component 112ml, dialysis, liquid freezing drying in the film.
The raw product 245mg that obtains like this, water-soluble, through Sephadex G-50 post deionized water chromatography, active component 80ml, lyophilize gets the 120mg white powder, and this thing is water-soluble again, through Sephadex G-75 column chromatography, collect the active component lyophilize, obtain 62mg C-1027 white powder highly finished product, its physico-chemical property and biological characteristics are as previously mentioned.
Description of drawings:
Fig. 1: the fibrillae of spores of C-1027 bacterial strain (300 *)
Fig. 2: the spore of C-1027 bacterial strain (15000 *)
The UV spectrum of Fig. 3: C-1027
The infrared spectra of Fig. 4: C-1027

Claims (6)

1, a kind of manufacture method that can extract large-molecular peptides antitumor antibiotics C-1027 from microorganisms cultures is characterized in that it is from streptomyces C-1027 bacterial strain, is prepared with the general method that extracts tunning.
2, manufacture method according to claim 1, the fibrillae of spores that it is characterized in that the C-1027 bacterial strain is until the ripple song, the spore cylindricality, smooth surface, aerial mycelium is that pale yellow white extremely light olive moccasin look often has shallow brown or shallow Chinese cassia tree color, colourless or the creamy of base silk, full cellular water hydrolysis products contains the LL-diaminopimelic acid.
3, manufacture method according to claim 2, it is characterized in that the C-1027 bacterial strain, can in various complete synthesis, semi-synthetic or natural mediums, cultivate, these substratum contain usually and are suitable for cultivating actinomycetic carbon source, nitrogenous source and an amount of inorganic salts, fermentation culture is generally carried out under vibration or aeration-agitation aerobic condition, culture temperature 27-30 ℃, pH value neutrality, incubation time 2-5 days.
4, manufacture method according to claim 1, it is characterized in that for from culturing filtrate, extracting the C-1027 antibiotics, available saltouing, the hydrophobicity chromatography, ion exchange chromatography, adsorption chromatography, gel permeation chromatographies etc. are handled individually or in combination, throw out is centrifugal, separate, filter, desalination, refining, wash-out, concentrate, lyophilize, finally obtain the pure product of C-1027 white powder, show single band by the SDS-polyacrylamide gel electrophoresis, Sephadex G-50 column chromatography shows simple spike, TSK-gel G.2000SW high pressure liquid chromatography is a simple spike, LKB iso-electric point electrophoresis is single band, proves that gained C-1027 is a monomer.
5, manufacture method according to claim 4 is characterized in that the antibiotic molecular weight of C-1027 that extracts preparation with this method is about 15000, and the-terminal amino acid during amino acid is formed is a L-Ala.
6, manufacture method according to claim 4, it is characterized in that compound with this method preparation, not only the gram positive bacterium growth there is stronger restraining effect, also has tangible anti-tumor activity, generate the assay method inspection with the clone, half casualty-producing concentrations to the human hepatocellular carcinoma BEL-7402 cell is stronger 64 times and 454 times respectively than Zorubicin and mitomycin, and the mouse transplanted solid tumor is comprised S 180Sarcoma, U 14Cervical cancer and Harding-passey melanoma all have obvious restraining effect, and therefore, the resulting C-1027 microbiotic of the present invention is useful as antitumor drug.
CN 88102759 1988-05-13 1988-05-13 The manufacture method of new antitumor antibiotic C-1027 Pending CN1037539A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 88102759 CN1037539A (en) 1988-05-13 1988-05-13 The manufacture method of new antitumor antibiotic C-1027

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 88102759 CN1037539A (en) 1988-05-13 1988-05-13 The manufacture method of new antitumor antibiotic C-1027

Publications (1)

Publication Number Publication Date
CN1037539A true CN1037539A (en) 1989-11-29

Family

ID=4832291

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 88102759 Pending CN1037539A (en) 1988-05-13 1988-05-13 The manufacture method of new antitumor antibiotic C-1027

Country Status (1)

Country Link
CN (1) CN1037539A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1296347C (en) * 2003-12-08 2007-01-24 中国科学院海洋研究所 Compound of antitumor antibiotic of new carbon framework as well as preparation method and application
CN109957591A (en) * 2017-12-22 2019-07-02 中国医学科学院医药生物技术研究所 The preparation process amelioration and quality standard of double targeting ligand lidamycin DTLL is formulated

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1296347C (en) * 2003-12-08 2007-01-24 中国科学院海洋研究所 Compound of antitumor antibiotic of new carbon framework as well as preparation method and application
CN109957591A (en) * 2017-12-22 2019-07-02 中国医学科学院医药生物技术研究所 The preparation process amelioration and quality standard of double targeting ligand lidamycin DTLL is formulated

Similar Documents

Publication Publication Date Title
CN1867664A (en) Production of tacrolimus (fk-506) using new streptomyces species
JPS58212787A (en) Substance ws6049, its preparation and anticancer agent containing the same as active constituent
CN1320099C (en) Method for preparing epsilon-polylysine and salts thereof by using northern sporotrichum PL 6-3
CN1644677A (en) Bacillus and its use of preparation of gama-polycysteine
CN1165547C (en) Novel lantibiotic related to actagardine, and process for preparation and use thereof
CN1286692A (en) Substances KF-1040 and process for producing same
CN101628931A (en) Antitumor antibiotics, pharmaceutically acceptable salts thereof, preparation method thereof and use thereof
CN1037539A (en) The manufacture method of new antitumor antibiotic C-1027
CN1161455C (en) Strain Producing remarkable amount of epsilon-poly-L-Lysine and process for producing same
EP0322937A2 (en) Derivatives of paraherquamide isolated from a fermentation broth active as antiparasitic agents
CN1252079C (en) Novel substance having physiological activity, process for producing the same, and use
CN1231340A (en) Anti-tumor antibiotic and microbiological formentation production method thereof
JP2593495B2 (en) Compound TAN-999, production method and use thereof
SU539538A3 (en) Method for producing metabolite 2776
CN1025682C (en) Microbiological process for making UK-61,689 and microorganism useful therefor
CN1033591C (en) Production of pradimicin antibiotics
RU2013448C1 (en) Strain streptomyces bambergiensis - a producer of moenomycin a
JPH02191280A (en) Helminthic biologically converted product
CA1122526A (en) Biologically active substance, preparation process and drugs containing same
JP3107455B2 (en) New antibiotic MI481-42F4-A and method for producing the same
CN1022765C (en) Preparation method of cell variety mycomycin of new antibiotic
CN1071950A (en) New antitumor antibiotics
FR2463618A1 (en) NOVEL ANTIBIOTIC AMINOGLYCOSIDE AND ITS PRODUCTION
CN1014527B (en) Prepn method of new antibiotic sr-1223
KR840000934B1 (en) Process for preparing antibiotic sf-2080 a and sf-2080 b

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication